Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
18005 | 571 | 26.9 | 63% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
76 | 3 | NEUROSCIENCES//DOPAMINE//SEROTONIN | 81359 |
218 | 2 | SEROTONIN//5 HT1A RECEPTOR//5 HT2A RECEPTOR | 20633 |
18005 | 1 | ARYLPIPERAZINES//5 HT1A LIGANDS//LONG CHAIN ARYLPIPERAZINES | 571 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ARYLPIPERAZINES | authKW | 940460 | 8% | 37% | 48 |
2 | 5 HT1A LIGANDS | authKW | 462179 | 2% | 79% | 11 |
3 | LONG CHAIN ARYLPIPERAZINES | authKW | 430343 | 2% | 62% | 13 |
4 | 5 HT1A RECEPTOR LIGANDS | authKW | 361408 | 2% | 48% | 14 |
5 | NEW DRUGS | address | 309068 | 3% | 34% | 17 |
6 | 1 ARYLPIPERAZINE | authKW | 285199 | 1% | 67% | 8 |
7 | 5 HT1A 5 HT2A RECEPTOR LIGANDS | authKW | 222814 | 1% | 83% | 5 |
8 | 5 HT1A AND 5 HT2A RECEPTOR AFFINITY | authKW | 213903 | 1% | 100% | 4 |
9 | DRUG TECHNOL | address | 194647 | 3% | 20% | 18 |
10 | PURINE 2 6 DIONES | authKW | 190982 | 1% | 71% | 5 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 15712 | 49% | 0% | 279 |
2 | Pharmacology & Pharmacy | 1546 | 32% | 0% | 180 |
3 | Chemistry, Organic | 833 | 18% | 0% | 105 |
4 | Chemistry, Multidisciplinary | 657 | 24% | 0% | 136 |
5 | Crystallography | 551 | 9% | 0% | 51 |
6 | Computer Science, Interdisciplinary Applications | 9 | 2% | 0% | 10 |
7 | Mathematical & Computational Biology | 5 | 1% | 0% | 5 |
8 | Chemistry, Physical | 4 | 5% | 0% | 31 |
9 | Biochemical Research Methods | 4 | 2% | 0% | 11 |
10 | Chemistry, Analytical | 4 | 3% | 0% | 16 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NEW DRUGS | 309068 | 3% | 34% | 17 |
2 | DRUG TECHNOL | 194647 | 3% | 20% | 18 |
3 | DIPARTIMENTO FARMACOL G SEGRE | 122227 | 1% | 57% | 4 |
4 | CAJAL NEUROPHARMACOL | 106952 | 0% | 100% | 2 |
5 | NEW DRUG | 91375 | 4% | 9% | 20 |
6 | PHARMACOL SCREENING | 58519 | 2% | 12% | 9 |
7 | CHEM DRUGS | 55620 | 3% | 7% | 16 |
8 | ICTM CHEM | 54994 | 1% | 17% | 6 |
9 | AMINO ACIDES PROT | 53476 | 0% | 100% | 1 |
10 | CATTAR MANZIL PALACE MED CHEM | 53476 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | FARMACO | 23930 | 5% | 2% | 28 |
2 | POLISH JOURNAL OF PHARMACOLOGY | 23418 | 3% | 3% | 17 |
3 | ARCHIV DER PHARMAZIE | 18887 | 7% | 1% | 39 |
4 | JOURNAL OF MEDICINAL CHEMISTRY | 11511 | 12% | 0% | 68 |
5 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 9164 | 7% | 0% | 40 |
6 | FARMACO-EDIZIONE SCIENTIFICA | 5207 | 2% | 1% | 9 |
7 | ACTA POLONIAE PHARMACEUTICA | 3720 | 2% | 1% | 10 |
8 | MEDICINAL CHEMISTRY RESEARCH | 2827 | 2% | 0% | 13 |
9 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2713 | 6% | 0% | 36 |
10 | PHARMAZIE | 2625 | 4% | 0% | 21 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KOWALSKI, P , MITKA, K , JASKOWSKA, J , DUSZYNSKA, B , BOJARSKI, AJ , (2013) NEW ARYLPIPERAZINES WITH FLEXIBLE VERSUS PARTLY CONSTRAINED LINKER AS SEROTONIN 5-HT1A/5-HT7 RECEPTOR LIGANDS.ARCHIV DER PHARMAZIE. VOL. 346. ISSUE 5. P. 339 -348 | 24 | 75% | 5 |
2 | BIELENICA, A , KOZIOL, AE , STRUGA, M , (2013) COMPUTATIONAL METHODS IN DETERMINATION OF PHARMACOPHORE MODELS OF 5-HT1A, 5-HT2A AND 5-HT7 RECEPTORS.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 13. ISSUE 7. P. 933-951 | 36 | 46% | 0 |
3 | BIELENICA, A , KOZIOL, AE , STRUGA, M , (2013) BINDING MODES OF CHAIN ARYLPIPERAZINES TO 5-HT1A, 5-HT2A AND 5-HT7 RECEPTORS.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 13. ISSUE 10. P. 1516-1539 | 38 | 41% | 4 |
4 | PALUCHOWSKA, MH , BOJARSKI, AJ , CHARAKCHIEVA-MINOL, S , WESOLOWSKA, A , (2002) ACTIVE CONFORMATION OF SOME ARYLPIPERAZINE POSTSYNAPTIC 5-HT1A RECEPTOR ANTAGONISTS.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. VOL. 37. ISSUE 4. P. 273-283 | 24 | 73% | 15 |
5 | LOPEZ-RODRIGUEZ, ML , AYALA, D , BENHAMU, B , MORCILLO, MJ , VISO, A , (2002) ARYLPIPERAZINE DERIVATIVES ACTING AT 5-HT1A RECEPTORS.CURRENT MEDICINAL CHEMISTRY. VOL. 9. ISSUE 4. P. 443 -469 | 54 | 27% | 117 |
6 | NOWAK, M , KOLACZKOWSKI, M , PAWLOWSKI, M , BOJARSKI, AJ , (2006) HOMOLOGY MODELING OF THE SEROTONIN 5-HT1A RECEPTOR USING AUTOMATED DOCKING OF BIOACTIVE COMPOUNDS WITH DEFINED GEOMETRY.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 49. ISSUE 1. P. 205-214 | 23 | 52% | 65 |
7 | HEROLD, F , KROL, M , KLEPS, J , NOWAK, G , (2006) SYNTHESIS OF NEW HEXAHYDRO AND OCTAHYDROPYRIDO[1,2-C]PYRIMIDINE DERIVATIVES WITH AN ARYLPIPERAZINE MOIETY AS LIGANDS FOR 5-HT1A AND 5-HT2A RECEPTORS. PART 4.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. VOL. 41. ISSUE 1. P. 125 -134 | 21 | 62% | 11 |
8 | CHLON-RZEPA, G , ZMUDZKI, P , PAWLOWSKI, M , WESOLOWSKA, A , SATALA, G , BOJARSKI, AJ , JABLONSKI, M , KALINOWSKA-TLUSCIK, J , (2014) NEW 7-ARYLPIPERAZINYLALKYL-8-MORPHOLIN-4-YL-PURINE-2,6-DIONE DERIVATIVES WITH ANXIOLYTIC ACTIVITY - SYNTHESIS, CRYSTAL STRUCTURE AND STRUCTURE-ACTIVITY STUDY.JOURNAL OF MOLECULAR STRUCTURE. VOL. 1067. ISSUE . P. 243-251 | 15 | 65% | 1 |
9 | FIORINO, F , SEVERINO, B , DE ANGELIS, F , PERISSUTTI, E , MAGLI, E , FRECENTESE, F , ESPOSITO, A , MASSARELLI, P , NENCINI, C , SANTAGADA, V , ET AL (2010) NEW 5-HT1A RECEPTOR LIGANDS CONTAINING A N '-CYANOISONICOTINAMIDINE NUCLEUS: SYNTHESIS AND IN VITRO PHARMACOLOGICAL EVALUATION.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. VOL. 20. ISSUE 9. P. 2978-2982 | 18 | 58% | 4 |
10 | BOJARSKI, AJ , MOKROSZ, MJ , MINOL, SC , KOZIOL, A , WESOLOWSKA, A , TATARCZYNSKA, E , KLODZINSKA, A , CHOJNACKA-WOJCIK, E , (2002) THE INFLUENCE OF SUBSTITUTION AT AROMATIC PART OF 1,2,3,4-TETRAHYDROISOQUINOLINE ON IN VITRO AND IN VIVO 5-HT1A/5-HT2A RECEPTOR ACTIVITIES OF ITS 1-ADAMANTOYLOAMINOALKYL DERIVATIVES.BIOORGANIC & MEDICINAL CHEMISTRY. VOL. 10. ISSUE 1. P. 87-95 | 18 | 69% | 11 |
Classes with closest relation at Level 1 |